Annual Report and Accounts for the year ended 30 June 2019
Download the PDF of the
Annual Report 2019
Dechra is a global specialist veterinary pharmaceuticals and related products business.
Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide.
It is our mission to develop products sustainably to improve the welfare of animals globally.
Countries in which
our products are sold
via a distributor
Countries in which our
sales and marketing
teams are based
Read more on Growing Our Geographical Footprint
We continued to execute
our strategy in relation to our
pipeline delivery, portfolio focus,
geographic expansion and
Read more on the Chairman's View
Our existing business performed strongly this
year and was further enhanced by the realisation
of significant revenue synergies. The Group’s
balance sheet is strong and we continue
to invest both organically and through
acquisitions to deliver shareholder value.
AER: +18.3% CER: +17.5%
AER: +28.4% CER: +27.3%
AER: +17.7% CER: +16.6%
AER: +23.9% CER: +23.9%
AER: +14.4% CER: +13.5%
AER: (18.8%) CER: (19.6%)
Recent acquisitions performing ahead of expectations.
CAP outperformance in all key markets.
FAP growth continuing.
Numerous product registrations achieved, and new development opportunities secured.
Read more on Financial Performance
Since 2013, our priorities for each Strategic Growth Driver and Enabler have been clearly defined and communicated and are outlined on Our Achievements and Progress. In this online Annual Report we describe the progress we have made towards achieving our
We are implementing a strong technology platform
to enable us to operate efficiently. We also offer CPD
training via our e-learning system to veterinarians and
Our people strategy underpins everything we do in the
business. We have a well defined plan to build talent,
develop people and strengthen the Dechra culture.
Manufacturing is a key competency of the Group; the
prime objective is to deliver safe, efficacious, costeffective,
quality products. Our products are distributed to wholesalers and distributors
through two major logistics sites.
Deliver our pipeline on time,
at the right costs and with
the expected returns. Refill
the pipeline so that we get
a constant flow of new
products in future years.
Maximise our revenue
by increasing market
penetration, focusing on
sectors within CAP,
Equine, FAP and Nutrition.
Leverage our product
portfolio into new
geographic regions through
distribution partners, in-country
new country product
Expand our geographical
footprint and/or enhance
our product portfolio
Read more on Delivering our Strategy
A key strategic priority for the Group is the delivery and strength of the pipeline. We currently have 56 projects in the product development process.
Read more on our Product Development
Strategy in Action
Delivering our pipeline through licensing opportunities
Read more on our Pipeline Delivery
Dechra Dog & Cat App
Read more on our Portfolio Focus
Laboratorios Vencofarma do Brasil Ltda, Brazil
Read more on our Geographical Expansion and Acquisition